The Valley Desk

NCT00670930 · Interventional trial

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Overall registry status Completed

Phase 4

Conditions Allergic Asthma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov